• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《基因组蛋白质组与生物信息学报：英文版》 >Kinase–substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer

Kinase–substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer

         
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

The estrogen receptor（ER）-negative breast cancer subtype is aggressive with few treatment options available. To identify specific prognostic factors for ER-negative breast cancer, this study included 705,729 and 1034 breast invasive cancer patients from the Surveillance, Epidemiology, and End Results（SEER） and The Cancer Genome Atlas（TCGA） databases, respectively. To identify key differential kinase–substrate node and edge biomarkers between ER-negative and ERpositive breast cancer patients, we adopted a network-based method using correlation coefficients between molecular pairs in the kinase regulatory network. Integrated analysis of the clinical and molecular data revealed the significant prognostic power of kinase–substrate node and edge features for both subtypes of breast cancer. Two promising kinase–substrate edge features, CSNK1A1–NFATC3 and SRC–OCLN, were identified for more accurate prognostic prediction in ERnegative breast cancer patients.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号